The sunny city of San Diego, California might be known for surfing and hiking, but for Ashley Zolfaghari, it was her entry point into an interest in scientific research that she’s cultivated ever since. “My journey with research started when I was pretty young,” said Zolfaghari, now a senior…

Notre Dame AAAS Fellows Beth Archie, Peter…

Students from almost every discipline at the University of Notre Dame spent several days preparing presentations on one of the world’s most pressing global health challenges: tuberculosis.

Two researchers from the University of Notre Dame are recieving recognition for publications and images from the Notre Dame Integrated Imaging Facility (NDIIF). Each year, the NDIIF provides imaging awards to recognize and honor researchers who use the facility…

A study from the University of Notre Dame, Massachusetts General Hospital and the National Institutes of Health has identified a combination of medications that may improve blood flow within granulomas, benefiting drug delivery. Published in the Proceedings of the National Academy of Sciences, the study leverages decades of cancer research...

For over 8,000 years, the “white death,” tuberculosis (TB), has plagued humankind. Its effects are described in Biblical verses and appear in mummies from Ancient Egypt. Those infected with Mycobacterium tuberculosis, which causes TB, can now be cured thanks to modern health advancements —…

University of Notre Dame researchers will gather new insights about cancerous tumors by taking their science to space aboard NASA’s 30th SpaceX commercial resupply services mission.

As the University of Notre Dame celebrates International Women’s Day and Women’s History Month, meet eight individuals who are accelerating progress in their respective fields and advancing the University’s mission as a leading research institution that is a means for good in the …

In the West of Ireland, we know Sharon Stack as an advocate and cofounder of Biseach, a cancer research collaboration project that builds on the complementary strengths of Galway and Notre Dame cancer research.

Paul Bohn, the Arthur J. Schmitt Professor of Chemical and Biomolecular Engineering and professor of chemistry and biochemistry at the University of Notre Dame, has been named the inaugural director of the new Bioengineering…

Nine University of Notre Dame graduate students will compete for $4,500 in prize money during the annual Shaheen Three Minute Thesis (3MT) competition. The competition will take place from 5 to 7 p.m. Wednesday (Feb. 28) inside Jordan Auditorium at the Mendoza College of Business on campus. It is open...

The University of Notre Dame has received a Collaborative Pairs Pilot Project Award from the Chan Zuckerberg Initiative to study genes that affect neurodegenerative diseases.

Rhona Feltzer Rhona Feltzer, Laboratory Program Manager for the Mobashery and Chang laboratories, has been…

If Schnell has a mathematician’s mind, he also has a philosopher’s heart and a theologian’s soul. He distributes a motto for the college on bookmarks: Spes in caelis, pes in terris. Hope in heaven, feet on earth …

Neoantigens, which are molecules found on tumor cells that incorporate mutations, help our immune system fight cancers and could be the most promising components of future cancer vaccines—if only scientists knew with a high degree of certainty which neoantigens work. A collaboration of scientists…

In a new study in NPJ Genomic Medicine, researchers at the University of Notre Dame have found that a largely understudied cell could offer new insight into how the aggressive, primary brain cancer is able to resist immunotherapy.

Four PhD students at the University of Notre Dame have joined the Eck Institute for Global Health as graduate research fellows. The Institute will support the students as they pursue topics…

Although it’s well-known that fragile X is caused by the FMR1 gene, it’s less understood how the disorder physically affects brain development and function. Christopher Patzke at the University of Notre Dame is collaborating with fragile X patients and families to study the disorder.

Researchers have developed a new, lightning-fast method to detect “extracellular RNA,” or exRNA, which will aid in early detection of diseases including cancer, heart disease, HIV and other life-threatening conditions.

What happens when previously treatable cancers become drug-resistant? Jianneng Li, Archibald Assistant Professor in the Department of Biological Sciences, is trying to answer that question by conducting critical research on prostate cancer.